{
  "id": "552440452c8b63434a00000b",
  "type": "yesno",
  "question": "Are ACTA1 (alpha actin) and NEB (nebulin) genes related to nemaline myopathy?",
  "ideal_answer": "Yes, most nemaline myopathy patients have mutations in the nebulin (NEB) or skeletal muscle alpha-actin (ACTA1) genes.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/22407809",
    "http://www.ncbi.nlm.nih.gov/pubmed/22358459",
    "http://www.ncbi.nlm.nih.gov/pubmed/15495263",
    "http://www.ncbi.nlm.nih.gov/pubmed/11257471",
    "http://www.ncbi.nlm.nih.gov/pubmed/15564032",
    "http://www.ncbi.nlm.nih.gov/pubmed/16945536",
    "http://www.ncbi.nlm.nih.gov/pubmed/12805120",
    "http://www.ncbi.nlm.nih.gov/pubmed/19648653",
    "http://www.ncbi.nlm.nih.gov/pubmed/20012312",
    "http://www.ncbi.nlm.nih.gov/pubmed/11166164"
  ],
  "snippets": [
    {
      "text": "Nemaline myopathy (NM) is a group of congenital myopathies, characterized by the presence of distinct rod-like inclusions \"nemaline bodies\" in the sarcoplasm of skeletal muscle fibers. To date, ACTA1, NEB, TPM3, TPM2, TNNT1, and CFL2 have been found to cause NM.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22407809",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Nemaline myopathy (NM) is the most common congenital myopathy and is caused by mutations in various genes including NEB (nebulin), TPM2 (beta-tropomyosin), TPM3 (gamma-tropomyosin), and ACTA1 (skeletal alpha-actin). 20-25% of NM cases carry ACTA1 defects and these particular mutations usually induce substitutions of single residues in the actin protein. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22358459",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Nemaline myopathy (NM) is a genetically and clinically heterogenous muscle disorder, which is myopathologically characterized by nemaline bodies. Mutations in six genes have been reported to cause NM: Nebulin (NEB Pelin 1999), alpha-skeletal muscle actin (ACTA1 Nowak 1999), alpha-slow tropomyosin (TPM3 Laing 1995), beta-tropomyosin (TPM2 Donner 2002), slow troponin T (TNNT1 Johnston 2000) and cofilin 2 (CFL2 Agrawal 2007). The majority of cases are due to mutation in NEB and ACTA1. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20012312",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Nemaline myopathy is a heterogenous form of congenital myopathy characterised by a variable spectrum of clinical features, predominated in the severe form by profound muscle hypotonia and weakness accompanied by respiratory insufficiency. The clinical variability, with differing age of onset and severity of symptoms makes the diagnosis of nemaline myopathy difficult in some cases. Severe forms of nemaline myopathy may be caused by mutation of a number of different genes: skeletal muscle actin (ACTA1), nebulin (NEB) and alpha-tropomyosin (TPM3), all of which encode components of the sarcomeric thin filaments of skeletal muscle. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19648653",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Most nemaline myopathy patients have mutations in the nebulin (NEB) or skeletal muscle alpha-actin (ACTA1) genes. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16945536",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We report muscle MRI findings of 10 patients from 8 families with nemaline myopathy. Patients with involvement of the nebulin (NEB) gene showed a consistent pattern of selective muscle involvement corresponding to clinical severity.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15564032",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Patients with nemaline myopathy secondary to mutations in the skeletal muscle alpha-actin (ACTA1) gene showed diffuse involvement of thigh and leg muscles with relative sparing of the gastrocnemii.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15564032",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Congenital myopathies are clinical and genetic heterogeneous disorders characterized by skeletal muscle weakness ranging in severity. Three major forms have been identified: actin myopathy, intranuclear rod myopathy, and nemaline myopathy. Nemaline myopathy is the most common of these myopathies and is further subdivided into seven groups according to severity, progressiveness, and age of onset. At present, five genes have been linked to congenital myopathies. These include alpha-actin (ACTA1), alpha- and beta-tropomyosin (TPM3 and TPM2), troponin T (TNNT1), and nebulin (NEB). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15495263",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Nemaline myopathy is a structural congenital myopathy which may show both autosomal dominant and autosomal recessive inheritance patterns. Mutations in three different genes have been identified as the cause of nemaline myopathy: the gene for slow alpha-tropomyosin 3 (TPM3) at 1q22-23, the nebulin gene (NEB) at 2q21.1-q22, and the actin gene (ACTA1) at 1q42.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11257471",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Nemaline myopathy is a clinically and genetically heterogeneous condition. The clinical spectrum ranges from severe cases with antenatal or neonatal onset and early death to late onset cases with only slow progression. Three genes are known to cause nemaline myopathy: the genes for nebulin (NEB) on chromosome 2q22, slow alpha-tropomyosin (TPM3) on chromosome 1q21 and skeletal muscle alpha-actin (ACTA1) on chromosome 1q42. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11166164",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Nemaline myopathy (NM) is the most common congenital myopathy and is caused by mutations in various genes including NEB (nebulin), TPM2 (beta-tropomyosin), TPM3 (gamma-tropomyosin), and ACTA1 (skeletal alpha-actin).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22358459",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Three genes are known to cause nemaline myopathy: the genes for nebulin (NEB) on chromosome 2q22, slow alpha-tropomyosin (TPM3) on chromosome 1q21 and skeletal muscle alpha-actin (ACTA1) on chromosome 1q42.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11166164",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Five genes have now been associated with nemaline myopathy: alpha-tropomyosin-3 (TPM3), alpha-actin (ACTA1), nebulin (NEB), beta-tropomysin (TPM2) and troponin T (TNNT1).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12805120",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Most nemaline myopathy patients have mutations in the nebulin (NEB) or skeletal muscle alpha-actin (ACTA1) genes.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16945536",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Severe forms of nemaline myopathy may be caused by mutation of a number of different genes: skeletal muscle actin (ACTA1), nebulin (NEB) and alpha-tropomyosin (TPM3), all of which encode components of the sarcomeric thin filaments of skeletal muscle.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19648653",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Five genes have now been associated with nemaline myopathy: alpha-tropomyosin-3 (TPM3), alpha-actin (ACTA1), nebulin (NEB), beta-tropomysin (TPM2) and troponin T (TNNT1).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12805120",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Three genes are known to cause nemaline myopathy: the genes for nebulin (NEB) on chromosome 2q22, slow alpha-tropomyosin (TPM3) on chromosome 1q21 and skeletal muscle alpha-actin (ACTA1) on chromosome 1q42.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11166164",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Mutations in three different genes have been identified as the cause of nemaline myopathy: the gene for slow alpha-tropomyosin 3 (TPM3) at 1q22-23, the nebulin gene (NEB) at 2q21.1-q22, and the actin gene (ACTA1) at 1q42.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11257471",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Most nemaline myopathy patients have mutations in the nebulin (NEB) or skeletal muscle alpha-actin (ACTA1) genes",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16945536",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Five genes have now been associated with nemaline myopathy: alpha-tropomyosin-3 (TPM3), alpha-actin (ACTA1), nebulin (NEB), beta-tropomysin (TPM2) and troponin T (TNNT1)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12805120",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Three genes are known to cause nemaline myopathy: the genes for nebulin (NEB) on chromosome 2q22, slow alpha-tropomyosin (TPM3) on chromosome 1q21 and skeletal muscle alpha-actin (ACTA1) on chromosome 1q42",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11166164",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Nemaline myopathy (NM) is the most common congenital myopathy and is caused by mutations in various genes including NEB (nebulin), TPM2 (beta-tropomyosin), TPM3 (gamma-tropomyosin), and ACTA1 (skeletal alpha-actin)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22358459",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Five genes have now been associated with nemaline myopathy: alpha-tropomyosin-3 (TPM3), alpha-actin (ACTA1), nebulin (NEB), beta-tropomysin (TPM2) and troponin T (TNNT1)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12805120",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Nemaline myopathy (NM) is the most common congenital myopathy and is caused by mutations in various genes including NEB (nebulin), TPM2 (beta-tropomyosin), TPM3 (gamma-tropomyosin), and ACTA1 (skeletal alpha-actin)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22358459",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Mutations in three different genes have been identified as the cause of nemaline myopathy: the gene for slow alpha-tropomyosin 3 (TPM3) at 1q22-23, the nebulin gene (NEB) at 2q21.1-q22, and the actin gene (ACTA1) at 1q42",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11257471",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Three genes are known to cause nemaline myopathy: the genes for nebulin (NEB) on chromosome 2q22, slow alpha-tropomyosin (TPM3) on chromosome 1q21 and skeletal muscle alpha-actin (ACTA1) on chromosome 1q42",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11166164",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Most nemaline myopathy patients have mutations in the nebulin (NEB) or skeletal muscle alpha-actin (ACTA1) genes",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16945536",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Severe forms of nemaline myopathy may be caused by mutation of a number of different genes: skeletal muscle actin (ACTA1), nebulin (NEB) and alpha-tropomyosin (TPM3), all of which encode components of the sarcomeric thin filaments of skeletal muscle",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19648653",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "http://www.uniprot.org/uniprot/NEBU_HUMAN",
    "http://www.disease-ontology.org/api/metadata/DOID:3191",
    "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D017696",
    "http://www.uniprot.org/uniprot/ACTS_CYPCA",
    "http://www.uniprot.org/uniprot/ACTS_ORYLA",
    "http://www.uniprot.org/uniprot/ACTS_ATRMM",
    "http://www.uniprot.org/uniprot/ACTS_CARAU",
    "http://www.uniprot.org/uniprot/ACTS_OREMO"
  ],
  "exact_answer": "Yes"
}